CONMED Corporation revised earnings guidance for the full year 2024. For the period, the company's revenue is expected to be between $1.330 billion and $1.355 billion, compared to the prior guidance range of between $1.340 billion and $1.365 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.72 USD | -1.03% | +5.00% | -31.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.77% | 2.3B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2024